Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

Unlocking The Secrets of Microvascular Obstruction: Digital Simulation and Circuit Analytics of MVO Detection In The Cath Lab

Presenter: Robert S. Schwartz

October 27, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

TCT 366: Hyperoxemic Supersaturated Oxygen Therapy in Patients With Acute Anterior Myocardial Infarction Reduces Infarct Size and Microvascular Obstruction – a Cardiac Magnet Resonance Imaging Analysis

Presenter: Andreas Schafer

October 26, 2023

Presentation TCT 2023

TCT 176: Angiography-derived Index of Microvascular Resistance Predicts Vessel-territory Microvascular Obstruction in Anterior-wall ST-segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention

Presenter: Jinying Zhou

October 26, 2023

Presentation TCT 2023

Microvascular Obstruction: New Developments in Cath-Lab based Detection, Diagnosis and Therapy Microvascular Obstruction: Catheter Based Detection and Treatment in the Cath Lab

Presenter: Robert Schwartz

October 26, 2023

Presentation TCT 2023

Addressing Microvascular Obstruction with SSO2

Presenter: Gregg Stone

October 25, 2023

Presentation TCT 2022

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

Presenter: Omid Akhavan

September 17, 2022

Presentation TCT 2020

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

Presenter: Matheus Santos

October 14, 2020

News Daily News

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Yael L. Maxwell

April 22, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

Presentation TCT Abstracts Posters 2019

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Presenter: Valgimigli M.

October 17, 2019

Presentation TCT Abstracts Posters 2019

Intracoronary Tirofiban Delivered by Controlled Flow Infusion: Marked Reduction of Microvascular Obstruction in a Porcine STEMI Model

Presenter: Robert Schwartz

September 29, 2019

Presentation TCT 2019

Importance of Infarct Size and Microvascular Obstruction in STEMI

Presenter: Suzanne de Waha

September 26, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

Advertisement

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Unlocking The Secrets of Microvascular Obstruction: Digital Simulation and Circuit Analytics of MVO Detection In The Cath Lab

Early Coronary Function Testing Improves Quality of Life in ANOCA

May 2025 Dispatch for the CV Team

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

TCT 366: Hyperoxemic Supersaturated Oxygen Therapy in Patients With Acute Anterior Myocardial Infarction Reduces Infarct Size and Microvascular Obstruction – a Cardiac Magnet Resonance Imaging Analysis

TCT 176: Angiography-derived Index of Microvascular Resistance Predicts Vessel-territory Microvascular Obstruction in Anterior-wall ST-segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention

Microvascular Obstruction: New Developments in Cath-Lab based Detection, Diagnosis and Therapy Microvascular Obstruction: Catheter Based Detection and Treatment in the Cath Lab

Addressing Microvascular Obstruction with SSO2

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Intracoronary Tirofiban Delivered by Controlled Flow Infusion: Marked Reduction of Microvascular Obstruction in a Porcine STEMI Model

Importance of Infarct Size and Microvascular Obstruction in STEMI

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content